Treatment advice in relation to COVID-19 virus outbreak
In connection with the COVID-19 virus outbreak, both the executive board of the Dutch Hematology Association (NVvH) and HOVON have set up guidelines for the treatment of non-COVID patients with hematological diseases. An addendum has also been drawn up for the use of hematological drugs in patients admitted for COVID-19 infection.
HOVON has set up working groups consisting of experts in Leukemia, Myeloma, CLL, Benign Hematology, Lymphomas, Stem Cell Transplantation, Supportive Care and LLPC.
In these working groups, discussions are held and designs are made for new studies. Treatment recommendations are also made for the treatment of patients outside of a study context.
Per disease group you will find the treatment advice in the submenu.